Back to News
Market Impact: 0.15
CRISPR Therapeutics Names A.J. Silver CFO As Raju Prasad Departs
Source: Nasdaq
Management & GovernanceHealthcare & Biotech
CRISPR Therapeutics said CFO Raju Prasad will step down to pursue other opportunities. A.J. Silver, currently senior vice president of finance, will succeed him; the article text cuts off before the effective date is fully stated.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Before Tera’s 95% Crash, Punches Were Thrown and Warnings Missed
- SpaceX and Tesla boards form special committees to review merger
- Tesla’s stock rises as Elon Musk drops new clues about a possible SpaceX merger
- A top medical technology stock is trading at a big discount. Here's why I'm buying
- Obsessed with CoreWeave and the AI trade? You're missing out on some great stocks
- Why is Netflix stock sliding today?
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AllMind Discusses Ontario's AI Economy with Minister Stephen Crawford and Supply Ontario CEO James Wallace
- AI Research Tools for SEDAR+, UK and ASX Filings